RecruitingNot ApplicableNCT05492422

Central Executive Training and Parent Training for ADHD

Evaluating the Efficacy of Sequenced Central Executive and Behavioral Parent Training for Children With ADHD

Sponsor

Florida State University

Enrollment

200 participants

Start Date

Oct 3, 2022

Study Type

INTERVENTIONAL

Conditions

ADHD

Summary

The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving children's working memory abilities. BPT is a therapeutic intervention that improves family functioning and child oppositional-defiant (ODD) symptoms by changing parenting behaviors. Their combined use is expected to provide complementary and additive benefits, particularly if CET is delivered before BPT.

Eligibility

Min Age: 8 YearsMax Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This study tests a combination of computer-based brain training (targeting working memory and executive function — the mental skills needed for planning and focus) along with a parent training program for children aged 8 to 12 with ADHD. The goal is to see if these two approaches together reduce ADHD symptoms better than either one alone. You may be eligible if: • Your child is aged 8 to 12 • Your child has a primary diagnosis of ADHD (all presentations eligible) • Both a parent and a teacher rate your child's ADHD symptoms in the clinical or borderline range You may NOT be eligible if: • Your child has a neurological, sensory, or motor impairment • Your child has a history of seizures, psychosis, bipolar disorder, or severe mood dysregulation • Your child has an intellectual disability (IQ below 70) • Your child is actively suicidal • The child or parent does not speak English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.